SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001021408-03-007845
Filing Date
2003-05-15
Accepted
2003-05-15 10:41:17
Documents
3
Period of Report
2003-03-31

Document Format Files

Seq Description Document Type Size
1 SALIX PHARMACEUTICALS, LTD. d10q.htm 10-Q 196486
3 CEO CERTIFICATION dex991.htm EX-99.1 3045
4 CFO CERTIFICATION dex992.htm EX-99.2 3088
  Complete submission text file 0001021408-03-007845.txt   204445
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23265 | Film No.: 03701683
SIC: 2834 Pharmaceutical Preparations